教職人員
|
林君榮
研究領域：藥物動力學及藥效學、細胞膜轉運蛋白、神經退化疾病
本職：教授 / 藥學專業學院院長 / 藥學系主任
| 最高學歷 | : | 美國密西根大學藥劑學博士 |
| 經歷 | : | Upjohn Center for Clinical Pharmacology 研究員 醫藥品查驗中心藥動審查員 臨床藥學所講師 臨床藥學所助理教授 藥學系副教授 藥學系教授 |
| 研究領域 | : | 藥物動力學及藥效學、細胞膜轉運蛋白、神經退化疾病 |
| 研究方向 | : | (1) 細胞膜轉運蛋白之功能與分子機轉以及其與臨床應用之研究 (2) 細胞膜轉運蛋白在疾病狀態下之調控 (3) 血腦屏障 (4) 藥動學與藥效學 |
| 研究題目 | : | 1. 神經退化疾病對血腦屏障穿透性之影響 2. 細胞膜轉運蛋白在疾病產生與治療之角色與其調控 |
| 老師的話 | : | 要怎麼收穫就要怎麼栽！盡心力後而順天。 |
| 研究室要求 | : | 訓練邏輯、組織以及思考等方面能力。培養負責、盡心以及盡力的態度。 |
| 研究室成員 | : | 近幾年研究生： 林俊翰 (2017年畢) 藥學所研究生期刊論文傑出獎 論文發表於 Biochemical Pharmacology 2017; 142: 216–228 李之瑀 (2019年畢) 藥學所佳作論文獎 論文分別發表於： Neuropathology and Applied Neurobiology 2019; 45:157-173 Brain Behavior and Immunity 2020; 84:59-71 賴柏軒 (2019年畢) 醫學院研究生期刊論文優等獎 論文發表於Journal of Neuroinflammation 2021; 18:35 王庭萱 (2020年畢) 論文分別發表於： Journal of Neuroinflammation 2021; 18:35 European Journal of Pharmacology 2022; 933:175256 周芳儀 (2021年畢) 論文發表於Neurobiology of Disease 2023; 177:106004 呂喬心 (2021年畢) 醫學院研究生期刊論文佳作獎 論文發表於 Molecular Neurobiology 2023; 60:369-381 張乃有 (2021年畢) 醫學院研究生期刊論文佳作獎 論文發表於 European Journal of Pharmacology 2022; 933:175256 陳靖雅 (2022年畢) 論文發表於Neurobiology of Disease 2023; 177:106004 江蕙伶 (2022年畢) (論文投稿中) 何錦瑞 (在學) 陳玟瑜 (在學) 郭姵君 (在學) |
| 招生名額 | : | 製藥科技組：博士班一名、碩士班一名 藥物生技組：碩班一名 |
Development and Clinical Application of a Real-World Population Pharmacokinetic Model of Rivaroxaban in Asian Patients with Atrial Fibrillation
(2026-06) Lai, Nian-Shiuan ; CHUN-JUNG LIN ; CHING-HUA KUO ; Peng, Yu-Fong ; CHIH-FEN HUANG ; SUNG-CHUN TANG ; SHIN-YI LIN ; SHU-WEN LIN
Equilibrative nucleoside transporter 2 modulates inosine catabolism to influence astrocyte metabolism and reactivity
(2025-10-28) Chang, Ya-Gin ; Lin, Hsin-Chuan ; Chang, Ching-Pang ; Lai, Hsing-Lin ; Chen, Hui-Mei ; Huang, Haoning ; Chang, Pei-Rong ; Wu, Ching-Wen ; Ho, Chin-Jui ; Chu, Ting ; CHUN-JUNG LIN ; Chern, Yijuang
Preclinical Evaluation of a Novel Molecule Targeting Nucleoside Homeostasis to Restore Energy Metabolism and Cognitive Function in Alzheimer's Disease.
(2025-10) Wu, Kuo-Chen ; Lin, Chien-Yu ; Tran, Thanh ; Lin, Jung-Hsing ; Yeh, Hsin-Hsien ; Ho, Chin-Jui ; Chern, Yijuang ; CHUN-JUNG LIN
Administration mode matters for 5-fluorouracil therapy: Physiologically based pharmacokinetic evidence for avoidance of myelotoxicity by continuous infusion but not intravenous bolus.
(2025-04) Chao, Chih-Jia ; Gardner, Iain ; CHUN-JUNG LIN ; KUN-HUEI YEH ; Lu, Wan-Chen ; Abduljalil, Khaled ; YUNN-FANG HO
Corrigendum to "Equilibrative nucleoside transporter 3 supports microglial functions and protects against the progression of Huntington's disease in the mouse model" [Brain Behav. Immun. 120 (2024) 413-429].
(2024-10) Lu, Ying-Sui ; Hung, Wei-Chien ; Hsieh, Yu-Ting ; Tsai, Pei-Yuan ; Tsai, Tsai-Hsien ; Fan, Hsiu-Han ; Chang, Ya-Gin ; Cheng, Hui-Kuei ; Huang, Shen-Yan ; Lin, Hsin-Chuan ; Lee, Yan-Hua ; Shen, Tzu-Hsiang ; Hung, Bing-Yu ; Tsai, Jin-Wu ; Dzhagalov, Ivan ; Cheng, Irene Han-Juo ; CHUN-JUNG LIN ; Chern, Yijuang ; Hsu, Chia-Lin
(2026-06) Lai, Nian-Shiuan ; CHUN-JUNG LIN ; CHING-HUA KUO ; Peng, Yu-Fong ; CHIH-FEN HUANG ; SUNG-CHUN TANG ; SHIN-YI LIN ; SHU-WEN LIN
Equilibrative nucleoside transporter 2 modulates inosine catabolism to influence astrocyte metabolism and reactivity
(2025-10-28) Chang, Ya-Gin ; Lin, Hsin-Chuan ; Chang, Ching-Pang ; Lai, Hsing-Lin ; Chen, Hui-Mei ; Huang, Haoning ; Chang, Pei-Rong ; Wu, Ching-Wen ; Ho, Chin-Jui ; Chu, Ting ; CHUN-JUNG LIN ; Chern, Yijuang
Preclinical Evaluation of a Novel Molecule Targeting Nucleoside Homeostasis to Restore Energy Metabolism and Cognitive Function in Alzheimer's Disease.
(2025-10) Wu, Kuo-Chen ; Lin, Chien-Yu ; Tran, Thanh ; Lin, Jung-Hsing ; Yeh, Hsin-Hsien ; Ho, Chin-Jui ; Chern, Yijuang ; CHUN-JUNG LIN
Administration mode matters for 5-fluorouracil therapy: Physiologically based pharmacokinetic evidence for avoidance of myelotoxicity by continuous infusion but not intravenous bolus.
(2025-04) Chao, Chih-Jia ; Gardner, Iain ; CHUN-JUNG LIN ; KUN-HUEI YEH ; Lu, Wan-Chen ; Abduljalil, Khaled ; YUNN-FANG HO
Corrigendum to "Equilibrative nucleoside transporter 3 supports microglial functions and protects against the progression of Huntington's disease in the mouse model" [Brain Behav. Immun. 120 (2024) 413-429].
(2024-10) Lu, Ying-Sui ; Hung, Wei-Chien ; Hsieh, Yu-Ting ; Tsai, Pei-Yuan ; Tsai, Tsai-Hsien ; Fan, Hsiu-Han ; Chang, Ya-Gin ; Cheng, Hui-Kuei ; Huang, Shen-Yan ; Lin, Hsin-Chuan ; Lee, Yan-Hua ; Shen, Tzu-Hsiang ; Hung, Bing-Yu ; Tsai, Jin-Wu ; Dzhagalov, Ivan ; Cheng, Irene Han-Juo ; CHUN-JUNG LIN ; Chern, Yijuang ; Hsu, Chia-Lin
Ai-Assisted Drug Repurposing to Accelerate the Development of Inhalable Combination Therapy for Idiopathic Pulmonary Fibrosis
(2025-09-01～) CHIA-RON YANG
The Investigation of the Roles of Equilibrative Nucleoside Transporters on Pathological Response and Disease Progression of Ischemic Stroke and Ischemia-Reperfusion Injury
(2023-08-01～) CHUN-JUNG LIN
The Investigation of the Roles of Equilibrative Nucleoside Transporters on Pathological Response and Disease Progression of Ischemic Stroke and Ischemia-Reperfusion Injury
(2022-08-01～) CHUN-JUNG LIN
The Investigation of the Roles of Equilibrative Nucleoside Transporters on Pathological Response and Disease Progression of Ischemic Stroke and Ischemia-Reperfusion Injury
(2021-08-01～) CHUN-JUNG LIN
通過改善腦能量流失來治療阿茲海默症(1/2)
(2021-01-01～) CHUN-JUNG LIN
(2025-09-01～) CHIA-RON YANG
The Investigation of the Roles of Equilibrative Nucleoside Transporters on Pathological Response and Disease Progression of Ischemic Stroke and Ischemia-Reperfusion Injury
(2023-08-01～) CHUN-JUNG LIN
The Investigation of the Roles of Equilibrative Nucleoside Transporters on Pathological Response and Disease Progression of Ischemic Stroke and Ischemia-Reperfusion Injury
(2022-08-01～) CHUN-JUNG LIN
The Investigation of the Roles of Equilibrative Nucleoside Transporters on Pathological Response and Disease Progression of Ischemic Stroke and Ischemia-Reperfusion Injury
(2021-08-01～) CHUN-JUNG LIN
通過改善腦能量流失來治療阿茲海默症(1/2)
(2021-01-01～) CHUN-JUNG LIN